Different durations of cognitive stimulation therapy for Alzheimer's disease: a systematic review and meta-analysis

被引:19
作者
Chen, Juexuan [1 ]
Duan, Yuting [1 ,2 ]
Li, Huanjie [3 ]
Lu, Liming [1 ]
Liu, Jihong [3 ]
Tang, Chunzhi [1 ]
机构
[1] Guangzhou Univ Chinese Med, Med Coll Acu Moxi & Rehabil, 232 Waihuandong Rd, Guangzhou 510000, Guangdong, Peoples R China
[2] Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong Chinese Med Clin Study Ctr, Kowloon Tong, Hong Kong, Peoples R China
[3] Guangzhou Univ Chinese Med, Foshan Hosp Tradit Chinese Med, 6 Qinren Rd, Foshan 528000, Peoples R China
基金
中国国家自然科学基金;
关键词
cognitive stimulation therapy; Alzheimer's disease; cognitive symptom; meta-analysis; DEMENTIA; HEALTH; PLASTICITY; EFFICACY; TRIAL;
D O I
10.2147/CIA.S210062
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to evaluate the efficacy of cognitive stimulation therapy (CST) of different durations for Alzheimer's disease (AD). Methods: A comprehensive search was carried out in three databases. The primary outcome was Mini-Mental State Examination (MMSE) score. We conducted a meta-analysis with Review Manager, version 5.3 and assessed the methodological quality of the included studies using the Cochrane Collaboration Recommendations assessment tool. Results: Treatment effects from the meta-analysis showed that CST plus acetylcholinesterase inhibitors (ChEIs) was better than the control assessed by MMSE. In addition, the meta-analysis indicated that long-term CST was better than short-term or maintenance CST. Conclusion: Our study confirmed that the combination of CST and drug treatment for AD is effective in AD, regardless of whether short-term CST, maintenance CST, or long-term CST is used. The long-term CST appears to be more effective.
引用
收藏
页码:1243 / 1254
页数:12
相关论文
共 32 条
[1]   Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series [J].
Abraha, Iosief ;
Rimland, Joseph M. ;
Trotta, Fabiana Mirella ;
Dell'Aquila, Giuseppina ;
Cruz-Jentoft, Alfonso ;
Petrovic, Mirko ;
Gudmundsson, Adalsteinn ;
Soiza, Roy ;
O'Mahony, Denis ;
Guaita, Antonio ;
Cherubini, Antonio .
BMJ OPEN, 2017, 7 (03)
[2]  
Aldehri Majed, 2018, Surg Neurol Int, V9, P58, DOI 10.4103/sni.sni_342_17
[3]  
[Anonymous], TREATM AV
[4]  
[Anonymous], COCHRANE HDB SYSTEMA
[5]  
[Anonymous], 2011, MAKING A DIFFERENCE
[6]  
[Anonymous], DEMENTIA SUPPORTING
[7]  
[Anonymous], PHARM INN NEUR
[8]   The Alzheimer's Disease Clinical Spectrum Diagnosis and Management [J].
Atri, Alireza .
MEDICAL CLINICS OF NORTH AMERICA, 2019, 103 (02) :263-+
[9]   Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus report [J].
Bordet, Regis ;
Ihl, Ralf ;
Korczyn, Amos D. ;
Lanza, Giuseppe ;
Jansa, Jelka ;
Hoerr, Robert ;
Guekht, Alla .
BMC MEDICINE, 2017, 15
[10]   A basic introduction to fixed-effect and random-effects models for meta-analysis [J].
Borenstein, Michael ;
Hedges, Larry V. ;
Higgins, Julian P. T. ;
Rothstein, Hannah R. .
RESEARCH SYNTHESIS METHODS, 2010, 1 (02) :97-111